Tolerance-inducing therapies in coeliac disease — mechanisms, progress and future directions
Tolerance-inducing therapies in coeliac disease — mechanisms, progress and future directions
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Coeliac disease is an autoinflammatory condition caused by immune reactions to cereal gluten proteins. Currently, the only available treatment for the condition is a lifelong avoidance of gluten proteins in the diet. There is an unmet need for alternative therapies. Coeliac disease has a strong association with certain HLA−DQ allotypes (DQ2.5, DQ2....
Alternative Titles
Full title
Tolerance-inducing therapies in coeliac disease — mechanisms, progress and future directions
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2925034184
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2925034184
Other Identifiers
ISSN
1759-5045,1759-5053
E-ISSN
1759-5053
DOI
10.1038/s41575-024-00895-3
